融合切片检查市场按类型、产品类型、程序类型和最终用户划分－2025-2030 年全球预测

融合切片检查市场预计在 2024 年达到 7.5172 亿美元，2025 年达到 8.0629 亿美元，到 2030 年达到 11.6131 亿美元，复合年增长率为 7.51%。

主要市场统计数据
基准年2024年	7.5172亿美元
预计2025年	8.0629亿美元
预测年份 2030	11.6131亿美元
复合年增长率（%）	7.51%

引入融合切片检查创新技术，彻底改变临床实践中前列腺癌的检测和诊断准确性

融合切片检查代表了前列腺癌诊断领域的一项开创性变革，它透过将先进的影像技术与标靶组织取样技术相结合，重新定义了诊断的准确性和临床疗效。透过将高解析度MRI扫描和超音波影像迭加与即时引导相结合，该方法克服了传统系统性切片检查的局限性，使临床医生能够以无与伦比的精确度识别可疑病变。随着影像融合平台的加速应用，前列腺癌检测领域将从「一刀切」式的方案演变为个人化的、针对特定病变的策略，优先考虑诊断的可靠性和患者的安全。

技术突破和策略伙伴关係如何重塑融合切片检查应用的未来轨迹

在不断发展的影像引导介入领域，多项变革性变革正在改变融合切片检查应用的发展轨迹。人工智慧驱动的影像分析技术的进步实现了即时病变表征和自动分割，减少了对操作员的依赖，并简化了术前规划。同时，机器人辅助平台的出现提高了稳定性和重复性，进一步缩小了诊断误差的视窗。这些技术飞跃与云端基础协作网路的成熟相辅相成，透过促进远距会诊和第二意见服务，将专家指导延伸到资源匮乏的地区。

评估2025年美国关税对设备成本和跨国合作的累积影响

随着美国于2025年实施新的关税，融合活体组织切片市场将对设备采购和供应链动态产生一系列连锁效应。对进口核磁共振造影系统、超音波设备和专用切片检查系统征收额外关税，已促使医院和诊断中心重新评估其资本投资框架。因此，医疗保健提供者正在探索替代筹资策略，例如本地组装伙伴关係和双重采购协议，以缓解设备采购成本的通膨压力。

揭示关键细分市场，揭示不同类型、产品、流程和最终用户的市场动态

深入的分割分析揭示了融合切片检查解决方案如何在不同的临床场景中产生共鸣。认知融合工作流程依赖临床医师的专业知识，在即时超音波引导下对影像资料集进行心理迭加。 MRI-MRI 融合系统将术前高解析度扫描与术中 MRI 影像进行融合，以优化病灶定位。

探索美洲、欧洲、中东和非洲地区以及亚太地区市场融合活体组织切片采用趋势和基础设施实力的区域差异

区域差异在融合活体组织切片技术的采用和发展中起着关键作用。在美洲，完善的医疗基础设施和健全的报销框架推动了该技术的快速应用，学术研究中心和三级医院推动了手术创新，尤其是在北美。拉丁美洲的新兴市场也在效仿，儘管速度较慢，因为医疗服务提供者面临预算限制，并检验长期成本效益。

重点介绍在融合切片检查生态系统中推动创新、策略合作伙伴关係和竞争差异化的产业领导者

各行各业的领导者正在积极塑造融合切片检查市场的竞争格局。领先的诊断成像集团正在推出新一代平台，将人工智慧融入融合演算法，以提高病变检测灵敏度并简化操作员介面。设备製造商和软体开发商之间的策略联盟正在催生整合式融合套件，将影像处理硬体、导航软体和云端分析功能融为一体。

产业领导者面临的策略挑战和可行步骤，以加强其市场定位并加速融合切片检查技术的采用

为了巩固现有发展动能并应对新兴挑战，产业领导者应优先投资人工智慧平台，以提高影像匹配精度并实现病变特征的自动化描述。与硬体供应商建立伙伴关係，可以促进自适应融合介面的共同开发，并确保与下一代MRI和超音波诊断设备的无缝整合。透过与製造外包，实现供应链多元化，可以进一步降低与关税相关的成本波动，并减少对单一供应商的依赖。

采用严谨的调查方法，透过强大的数据收集和分析提供全面的融合活体组织切片市场洞察

此项分析以稳健、多层次的调查方法为基础，旨在确保资料的完整性和可操作性。这个过程始于一个详尽的二次研究阶段，涵盖同行评审的期刊报导、监管备案文件、临床试验註册、会议论文集和行业白皮书。这些资讯来源为对技术趋势、流程有效性和法律规范建立了基础理解。

摘要融合活体组织切片进展的策略价值，并预测诊断领域变化中的未来发展方向

随着融合切片检查不断重新定义前列腺癌的诊断，先进影像技术、软体分析和标靶干预措施的融合凸显了向精准医疗的广泛转变。本文提出的全面洞察，重点阐述如何根据治疗方式、产品类型、诊疗程序和医疗环境进行细分，揭示精准医疗应用路径的细微差别。此外，区域差异和关税的影响凸显了在供应链管理和报销参与方面采取适应性策略的必要性。

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章市场动态

• 支持采用融合切片检查的监管核准和报销政策
• 对融合切片检查设备的投资将加速市场成长和创新
• 即时成像技术的进步将推动融合切片检查市场的成长
• 对个人化医疗的日益关注将推动融合切片检查应用的创新
• 整合人工智慧以增强影像引导融合切片检查程序
• 微创融合切片检查技术的进步改善了患者的治疗效果
• 科技公司与医疗保健提供者之间的合作优化了融合切片检查工作流程
• 开发适用于门诊的可携式、易于使用的融合切片检查系统
• 利用即时影像融合引导扩大标靶切片检查技术的使用
• MRI-超音波融合切片检查在前列腺癌的检测和管理中的应用日益广泛

第六章 市场洞察

• 波特五力分析
• PESTEL分析

第七章 2025年美国关税的累积影响

第 8 章 融合切片检查市场（按类型）

• 认知融合
• MRI-MRI融合
• MRI与超音波的融合

9. 融合切片检查市场（依产品类型）

• 耗材
  • 切片检查标记物
  • 显影剂
  • 针头和探针
  • 灭菌消毒套件
• 装置
  • 融合切片检查系统
  • 核磁共振造影系统
  • 超音波设备

第 10 章 融合切片检查市场（依手术类型）

• 经会阴入路
• 经直肠入路

第 11 章 融合切片检查市场（按最终用户）

• 诊断中心
• 医院
• 专科诊所

第 12 章：美洲融合切片检查市场

• 美国
• 加拿大
• 墨西哥
• 巴西
• 阿根廷

13. 欧洲、中东和非洲的融合切片检查市场

• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 阿拉伯聯合大公国
• 沙乌地阿拉伯
• 南非
• 丹麦
• 荷兰
• 卡达
• 芬兰
• 瑞典
• 奈及利亚
• 埃及
• 土耳其
• 以色列
• 挪威
• 波兰
• 瑞士

第 14 章：亚太融合切片检查市场

• 中国
• 印度
• 日本
• 澳洲
• 韩国
• 印尼
• 泰国
• 菲律宾
• 马来西亚
• 新加坡
• 越南
• 台湾

第十五章竞争格局

• 2024年市场占有率分析
• 2024年FPNV定位矩阵
• 竞争分析
  • Biobot Surgical Pte Ltd
  • Canon Inc.
  • Eigen Health
  • Esaote SpA
  • Exact Imaging, Inc.
  • Focal Healthcare
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies Inc.
  • Hologic, Inc.
  • KOELIS SAS
  • Koninklijke Philips NV
  • MedCom GmbH
  • MTT GmbH
  • Siemens Healthineers AG
  • UC-Care Medical Systems

第十六章 研究人工智慧

第十七章 研究统计

第十八章 研究联络人

第十九章 研究报导

第二十章 附录

The Fusion Biopsy Market was valued at USD 751.72 million in 2024 and is projected to grow to USD 806.29 million in 2025, with a CAGR of 7.51%, reaching USD 1,161.31 million by 2030.

KEY MARKET STATISTICS
Base Year [2024]	USD 751.72 million
Estimated Year [2025]	USD 806.29 million
Forecast Year [2030]	USD 1,161.31 million
CAGR (%)	7.51%

Introduction of Fusion Biopsy Innovations That Are Revolutionizing Prostate Cancer Detection and Diagnostic Accuracy Across Clinical Settings

Fusion biopsy represents a pioneering shift in prostate cancer diagnostics, uniting advanced imaging with targeted tissue sampling to redefine accuracy and clinical outcomes. By integrating high-resolution MRI scans or ultrasound imaging overlays with real-time guidance, this approach transcends the limitations of traditional systematic biopsy, allowing clinicians to identify suspicious lesions with unparalleled precision. As the adoption of image-fusion platforms accelerates, the landscape of prostate cancer detection evolves from a one-size-fits-all methodology to a personalized, lesion-specific strategy that prioritizes diagnostic confidence and patient safety.

Through continuous technological refinement, fusion biopsy has demonstrated its capacity to lower the rates of false negatives and reduce the need for repeat procedures, thereby enhancing patient experience and optimizing clinical workflows. Moreover, the expanded availability of systems that combine cognitive fusion techniques with fully integrated MRI-MRI and MRI-ultrasound fusion capabilities supports broader clinical uptake across both academic centers and community hospitals. As healthcare providers embrace these innovations, the ripple effects extend beyond individual patient encounters, setting new benchmarks for procedural efficiency, healthcare economics, and the overall standard of prostate cancer care.

How Technological Breakthroughs and Strategic Collaborations Are Redirecting the Future Trajectory of Fusion Biopsy Applications

In the ever-evolving domain of image-guided interventions, several transformative shifts are reshaping the trajectory of fusion biopsy applications. Advancements in artificial intelligence-driven image analysis have enabled real-time lesion characterization and automated segmentation, reducing operator dependency and streamlining preprocedural planning. Concurrently, the emergence of robotic assistance platforms has introduced heightened stability and reproducibility, further narrowing the margin for diagnostic error. These technological leaps are complemented by the maturation of cloud-based collaborative networks, which facilitate remote consultations and second-opinion services, thereby extending expert guidance to under-resourced regions.

Strategic collaborations between diagnostic imaging manufacturers and software developers are also redefining the ecosystem, as cross-industry partnerships accelerate innovation cycles and foster the co-creation of turnkey fusion solutions. In parallel, regulatory agencies have begun to adopt flexible review pathways for digital health integrations, paving the way for agile updates and iterative feature enhancements. Taken together, these developments are not merely incremental; they represent a paradigmatic shift toward a more connected, data-centric model of precision oncology, empowering clinicians to deliver targeted interventions with enhanced confidence and efficiency.

Assessing the Cumulative Consequences of United States Tariffs Implemented in 2025 on Equipment Costs and Cross-Border Collaboration

With the implementation of new tariffs by the United States in 2025, the fusion biopsy market has encountered a series of cascading effects on equipment procurement and supply chain dynamics. The imposition of additional duties on imported MRI machines, ultrasound devices, and specialized biopsy systems has led hospitals and diagnostic centers to reassess their capital expenditure frameworks. As a result, providers are exploring alternative sourcing strategies, including local assembly partnerships and dual-sourcing agreements, to mitigate the inflationary pressures on device acquisition costs.

Beyond direct cost implications, the tariff environment has incentivized stakeholders to strengthen domestic supply resilience. Manufacturers are increasingly evaluating nearshoring options for components such as fusion biopsy consoles, software modules, and consumable accessories. At the same time, cross-border collaborations have shifted toward licensing arrangements that favor onshore software deployment. In this context, market participants must navigate a delicate balance between maintaining technological sophistication and optimizing operational budgets. Ultimately, the tariff-driven recalibration of supply chains underscores the importance of adaptive procurement practices and proactive supplier relationship management to sustain long-term growth.

Unveiling Critical Segmentation Breakdowns That Illuminate Market Dynamics Across Types, Products, Procedures, and End Users

An in-depth segmentation analysis offers critical clarity into how fusion biopsy solutions resonate across diverse clinical scenarios. When classification is based on types, three distinct modalities emerge: cognitive fusion workflows rely on clinician expertise to mentally superimpose imaging datasets during real-time ultrasound guidance; MRI-MRI fusion systems use preprocedural high-resolution scans aligned with intraoperative MRI to optimize lesion targeting; and MRI-ultrasound fusion platforms integrate volumetric MRI reconstructions with live ultrasound feeds, delivering a versatile balance of accuracy and cost-effectiveness.

Turning to product types, the market bifurcates into consumables and equipment. Consumables encompass biopsy markers that provide lesion localization, contrast agents that enhance imaging clarity, precision needles and probes tailored for targeted sampling, and comprehensive sterilization and disinfection kits to maintain procedural safety. On the equipment front, a spectrum of devices supports the fusion workflow, from dedicated fusion biopsy systems equipped with integrated guidance software to the underlying MRI machines that supply high-definition scans and the ultrasound devices that facilitate dynamic, real-time visualization.

Procedure type further influences market adoption, with the transperineal approach gaining traction for its reduced infection risk and improved access to anterior prostate zones, while the transrectal method remains prevalent for its procedural familiarity. Finally, end users span diverse care settings, including diagnostic centers that prioritize outpatient efficiency, hospitals with multidisciplinary oncology teams, and specialty clinics focused on advanced urologic interventions. This multifaceted segmentation framework underscores how modality choice, product offerings, clinical approach, and care environment converge to shape the fusion biopsy landscape.

Exploring Regional Variances in Fusion Biopsy Adoption Trends and Infrastructure Strengths Across the Americas, EMEA, and Asia-Pacific Markets

Regional nuances play a pivotal role in shaping the adoption and advancement of fusion biopsy technologies. In the Americas, well-established healthcare infrastructures and robust reimbursement frameworks have facilitated rapid uptake, particularly in North America where academic research centers and tertiary care hospitals drive procedural innovation. Emerging markets in Latin America are following suit, albeit at a moderated pace, as providers contend with budget constraints and seek to validate long-term cost-effectiveness through clinical outcome studies.

Across Europe, the Middle East, and Africa, adoption patterns exhibit heterogeneity, with Western Europe leading in regulatory harmonization and cross-border collaborative research initiatives. In contrast, parts of the Middle East and Africa are prioritizing capacity building and skills development, leveraging public-private partnerships to introduce fusion platforms into tertiary hospitals. Meanwhile, Asia-Pacific markets are witnessing a surge in fusion biopsy installations driven by rising healthcare expenditure, growing awareness of prostate cancer screening, and government incentives aimed at expanding advanced diagnostic capabilities. Nationalized healthcare systems in some Asia-Pacific countries are also exploring centralized procurement models to negotiate favorable pricing for both equipment and consumables, thereby enhancing accessibility for broader patient populations.

Highlighting Leading Industry Players Driving Innovation, Strategic Partnerships, and Competitive Differentiation in the Fusion Biopsy Ecosystem

A diverse array of industry leaders is actively shaping the competitive contours of the fusion biopsy market. Major imaging conglomerates have introduced next-generation platforms that embed artificial intelligence into fusion algorithms, enhancing lesion detection sensitivity and streamlining operator interfaces. Strategic partnerships between device manufacturers and software developers have given rise to integrated fusion suites that combine imaging hardware, navigation software, and cloud-enabled analytics under a single umbrella.

Smaller specialized firms are also making waves, launching novel consumable portfolios that include biodegradable biopsy markers and advanced contrast agents designed for multiparametric imaging compatibility. Concurrently, several key players have expanded their footprints through targeted acquisitions, incorporating complementary technology assets and bolstering their global distribution networks. Collaborative alliances between universities, research institutes, and market incumbents further amplify the pace of innovation, as co-development agreements and clinical trial partnerships drive iterative refinements and expand the evidence base supporting fusion biopsy efficacy.

Strategic Imperatives and Actionable Steps for Industry Leaders to Strengthen Market Positioning and Accelerate Adoption of Fusion Biopsy Technologies

To capitalize on existing momentum and navigate emerging challenges, industry leaders should prioritize investments in artificial intelligence platforms that enhance image co-registration accuracy and automate lesion characterization. Cultivating partnerships with hardware vendors can facilitate the co-development of adaptable fusion interfaces, ensuring seamless integration with next-generation MRI and ultrasound devices. Diversifying supply chains by engaging multiple contract manufacturers for both equipment and consumables will further mitigate tariff-related cost fluctuations and reduce dependency on single-source suppliers.

Additionally, allocating resources toward comprehensive clinician training programs will accelerate institutional adoption and foster best practices in both transperineal and transrectal approaches. Engaging proactively with reimbursement authorities to demonstrate the long-term economic and clinical benefits of fusion biopsy will support favorable coverage decisions. Finally, embracing patient-centric digital solutions-such as remote procedure planning portals and post-procedure follow-up applications-can enhance care continuity and differentiate providers in a competitive landscape.

Rigorous Research Methodology Employed to Deliver Comprehensive Fusion Biopsy Market Insights Through Robust Data Collection and Analysis

This analysis is underpinned by a robust, multi-layered research methodology designed to ensure data integrity and actionable insights. The process commenced with an exhaustive secondary research phase, encompassing peer-reviewed journal articles, regulatory filings, clinical trial registries, conference proceedings, and industry whitepapers. These sources established a foundational understanding of technological trends, procedural efficacy, and regulatory frameworks.

Complementing the secondary effort, primary research involved in-depth interviews with a cross-section of stakeholders, including urologists, radiologists, healthcare administrators, procurement specialists, and technology partners. Qualitative insights gleaned from these conversations were systematically validated against quantitative datasets, enabling triangulation of key findings and the identification of emerging inflection points. Data synthesis and iterative analysis cycles were conducted to reconcile discrepancies and refine thematic narratives. This rigorous approach ensures that conclusions and recommendations reflect both empirical evidence and real-world stakeholder perspectives.

Summarizing the Strategic Value of Fusion Biopsy Advancements and Projecting the Path Forward Amidst Evolving Diagnostic Landscapes

As fusion biopsy continues to redefine prostate cancer diagnostics, its convergence of advanced imaging, software analytics, and targeted intervention underscores a broader shift toward precision medicine. The collective insights presented herein highlight how segmentation by modality, product type, procedure, and care setting reveals nuanced adoption pathways. Further, regional variations and tariff impacts underscore the need for adaptive strategies in supply chain management and reimbursement engagement.

Looking ahead, the most successful stakeholders will be those that integrate technological innovation with operational agility, foster collaborative partnerships, and maintain a relentless focus on clinical evidence. By leveraging the strategic recommendations and market intelligence provided in this report, decision-makers can navigate complexity, capitalize on emerging opportunities, and ultimately deliver superior patient outcomes in prostate cancer care.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Market Sizing & Forecasting

5. Market Dynamics

• 5.1. Regulatory approvals and reimbursement policies supporting fusion biopsy adoption
• 5.2. Investments in fusion biopsy devices accelerating market growth and innovation
• 5.3. Advancements in real-time imaging technologies driving fusion biopsy market growth
• 5.4. Growing focus on personalized medicine driving innovation in fusion biopsy applications
• 5.5. Integration of artificial intelligence enhancing image-guided fusion biopsy procedures
• 5.6. Advancements in minimally invasive fusion biopsy techniques improving patient outcomes
• 5.7. Collaborations among tech companies and healthcare providers potimizing fusion biopsy workflows
• 5.8. Development of portable and user-friendly fusion biopsy systems for outpatient settings
• 5.9. Expanding use of real-time imaging fusion guiding targeted biopsy procedures
• 5.10. Increasing adoption of MRI-ultrasound fusion biopsy in prostate cancer detection and management

6. Market Insights

• 6.1. Porter's Five Forces Analysis
• 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Fusion Biopsy Market, by Types

• 8.1. Introduction
• 8.2. Cognitive Fusion
• 8.3. MRI-MRI Fusion
• 8.4. MRI-Ultrasound Fusion

9. Fusion Biopsy Market, by Product Type

• 9.1. Introduction
• 9.2. Consumables
  • 9.2.1. Biopsy Markers
  • 9.2.2. Contrast Agents
  • 9.2.3. Needles & Probes
  • 9.2.4. Sterilization & Disinfection Kits
• 9.3. Equipment
  • 9.3.1. Fusion Biopsy Systems
  • 9.3.2. MRI Machines
  • 9.3.3. Ultrasound Devices

10. Fusion Biopsy Market, by Procedure Type

• 10.1. Introduction
• 10.2. Transperineal Approach
• 10.3. Transrectal Approach

11. Fusion Biopsy Market, by End-User

• 11.1. Introduction
• 11.2. Diagnostic Centers
• 11.3. Hospitals
• 11.4. Specialty Clinics

12. Americas Fusion Biopsy Market

• 12.1. Introduction
• 12.2. United States
• 12.3. Canada
• 12.4. Mexico
• 12.5. Brazil
• 12.6. Argentina

13. Europe, Middle East & Africa Fusion Biopsy Market

• 13.1. Introduction
• 13.2. United Kingdom
• 13.3. Germany
• 13.4. France
• 13.5. Russia
• 13.6. Italy
• 13.7. Spain
• 13.8. United Arab Emirates
• 13.9. Saudi Arabia
• 13.10. South Africa
• 13.11. Denmark
• 13.12. Netherlands
• 13.13. Qatar
• 13.14. Finland
• 13.15. Sweden
• 13.16. Nigeria
• 13.17. Egypt
• 13.18. Turkey
• 13.19. Israel
• 13.20. Norway
• 13.21. Poland
• 13.22. Switzerland

14. Asia-Pacific Fusion Biopsy Market

• 14.1. Introduction
• 14.2. China
• 14.3. India
• 14.4. Japan
• 14.5. Australia
• 14.6. South Korea
• 14.7. Indonesia
• 14.8. Thailand
• 14.9. Philippines
• 14.10. Malaysia
• 14.11. Singapore
• 14.12. Vietnam
• 14.13. Taiwan

15. Competitive Landscape

• 15.1. Market Share Analysis, 2024
• 15.2. FPNV Positioning Matrix, 2024
• 15.3. Competitive Analysis
  • 15.3.1. Biobot Surgical Pte Ltd
  • 15.3.2. Canon Inc.
  • 15.3.3. Eigen Health
  • 15.3.4. Esaote SpA
  • 15.3.5. Exact Imaging, Inc.
  • 15.3.6. Focal Healthcare
  • 15.3.7. Fujifilm Holdings Corporation
  • 15.3.8. GE HealthCare Technologies Inc.
  • 15.3.9. Hologic, Inc.
  • 15.3.10. KOELIS SAS
  • 15.3.11. Koninklijke Philips N.V.
  • 15.3.12. MedCom GmbH
  • 15.3.13. MTT GmbH
  • 15.3.14. Siemens Healthineers AG
  • 15.3.15. UC-Care Medical Systems

16. ResearchAI

17. ResearchStatistics

18. ResearchContacts

19. ResearchArticles

20. Appendix

LIST OF FIGURES

• FIGURE 1. FUSION BIOPSY MARKET RESEARCH PROCESS
• FIGURE 2. GLOBAL FUSION BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 3. GLOBAL FUSION BIOPSY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 4. GLOBAL FUSION BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL FUSION BIOPSY MARKET SIZE, BY TYPES, 2024 VS 2030 (%)
• FIGURE 6. GLOBAL FUSION BIOPSY MARKET SIZE, BY TYPES, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
• FIGURE 8. GLOBAL FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2030 (%)
• FIGURE 10. GLOBAL FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL FUSION BIOPSY MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
• FIGURE 12. GLOBAL FUSION BIOPSY MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 13. AMERICAS FUSION BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 14. AMERICAS FUSION BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES FUSION BIOPSY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 16. UNITED STATES FUSION BIOPSY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA FUSION BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA FUSION BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 19. ASIA-PACIFIC FUSION BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 20. ASIA-PACIFIC FUSION BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 21. FUSION BIOPSY MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 22. FUSION BIOPSY MARKET, FPNV POSITIONING MATRIX, 2024
• FIGURE 23. FUSION BIOPSY MARKET: RESEARCHAI
• FIGURE 24. FUSION BIOPSY MARKET: RESEARCHSTATISTICS
• FIGURE 25. FUSION BIOPSY MARKET: RESEARCHCONTACTS
• FIGURE 26. FUSION BIOPSY MARKET: RESEARCHARTICLES

LIST OF TABLES

• TABLE 1. FUSION BIOPSY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL FUSION BIOPSY MARKET SIZE, 2018-2024 (USD MILLION)
• TABLE 4. GLOBAL FUSION BIOPSY MARKET SIZE, 2025-2030 (USD MILLION)
• TABLE 5. GLOBAL FUSION BIOPSY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 6. GLOBAL FUSION BIOPSY MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
• TABLE 7. GLOBAL FUSION BIOPSY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 8. GLOBAL FUSION BIOPSY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
• TABLE 9. GLOBAL FUSION BIOPSY MARKET SIZE, BY TYPES, 2018-2024 (USD MILLION)
• TABLE 10. GLOBAL FUSION BIOPSY MARKET SIZE, BY TYPES, 2025-2030 (USD MILLION)
• TABLE 11. GLOBAL FUSION BIOPSY MARKET SIZE, BY COGNITIVE FUSION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 12. GLOBAL FUSION BIOPSY MARKET SIZE, BY COGNITIVE FUSION, BY REGION, 2025-2030 (USD MILLION)
• TABLE 13. GLOBAL FUSION BIOPSY MARKET SIZE, BY MRI-MRI FUSION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 14. GLOBAL FUSION BIOPSY MARKET SIZE, BY MRI-MRI FUSION, BY REGION, 2025-2030 (USD MILLION)
• TABLE 15. GLOBAL FUSION BIOPSY MARKET SIZE, BY MRI-ULTRASOUND FUSION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 16. GLOBAL FUSION BIOPSY MARKET SIZE, BY MRI-ULTRASOUND FUSION, BY REGION, 2025-2030 (USD MILLION)
• TABLE 17. GLOBAL FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 18. GLOBAL FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 19. GLOBAL FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 20. GLOBAL FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2030 (USD MILLION)
• TABLE 21. GLOBAL FUSION BIOPSY MARKET SIZE, BY BIOPSY MARKERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 22. GLOBAL FUSION BIOPSY MARKET SIZE, BY BIOPSY MARKERS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 23. GLOBAL FUSION BIOPSY MARKET SIZE, BY CONTRAST AGENTS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 24. GLOBAL FUSION BIOPSY MARKET SIZE, BY CONTRAST AGENTS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 25. GLOBAL FUSION BIOPSY MARKET SIZE, BY NEEDLES & PROBES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 26. GLOBAL FUSION BIOPSY MARKET SIZE, BY NEEDLES & PROBES, BY REGION, 2025-2030 (USD MILLION)
• TABLE 27. GLOBAL FUSION BIOPSY MARKET SIZE, BY STERILIZATION & DISINFECTION KITS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 28. GLOBAL FUSION BIOPSY MARKET SIZE, BY STERILIZATION & DISINFECTION KITS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 29. GLOBAL FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
• TABLE 30. GLOBAL FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
• TABLE 31. GLOBAL FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
• TABLE 32. GLOBAL FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, BY REGION, 2025-2030 (USD MILLION)
• TABLE 33. GLOBAL FUSION BIOPSY MARKET SIZE, BY FUSION BIOPSY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 34. GLOBAL FUSION BIOPSY MARKET SIZE, BY FUSION BIOPSY SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 35. GLOBAL FUSION BIOPSY MARKET SIZE, BY MRI MACHINES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 36. GLOBAL FUSION BIOPSY MARKET SIZE, BY MRI MACHINES, BY REGION, 2025-2030 (USD MILLION)
• TABLE 37. GLOBAL FUSION BIOPSY MARKET SIZE, BY ULTRASOUND DEVICES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 38. GLOBAL FUSION BIOPSY MARKET SIZE, BY ULTRASOUND DEVICES, BY REGION, 2025-2030 (USD MILLION)
• TABLE 39. GLOBAL FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
• TABLE 40. GLOBAL FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
• TABLE 41. GLOBAL FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 42. GLOBAL FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 43. GLOBAL FUSION BIOPSY MARKET SIZE, BY TRANSPERINEAL APPROACH, BY REGION, 2018-2024 (USD MILLION)
• TABLE 44. GLOBAL FUSION BIOPSY MARKET SIZE, BY TRANSPERINEAL APPROACH, BY REGION, 2025-2030 (USD MILLION)
• TABLE 45. GLOBAL FUSION BIOPSY MARKET SIZE, BY TRANSRECTAL APPROACH, BY REGION, 2018-2024 (USD MILLION)
• TABLE 46. GLOBAL FUSION BIOPSY MARKET SIZE, BY TRANSRECTAL APPROACH, BY REGION, 2025-2030 (USD MILLION)
• TABLE 47. GLOBAL FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 48. GLOBAL FUSION BIOPSY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 49. GLOBAL FUSION BIOPSY MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 50. GLOBAL FUSION BIOPSY MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 51. GLOBAL FUSION BIOPSY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 52. GLOBAL FUSION BIOPSY MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 53. GLOBAL FUSION BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 54. GLOBAL FUSION BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 55. AMERICAS FUSION BIOPSY MARKET SIZE, BY TYPES, 2018-2024 (USD MILLION)
• TABLE 56. AMERICAS FUSION BIOPSY MARKET SIZE, BY TYPES, 2025-2030 (USD MILLION)
• TABLE 57. AMERICAS FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 58. AMERICAS FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 59. AMERICAS FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
• TABLE 60. AMERICAS FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
• TABLE 61. AMERICAS FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
• TABLE 62. AMERICAS FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
• TABLE 63. AMERICAS FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 64. AMERICAS FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 65. AMERICAS FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 66. AMERICAS FUSION BIOPSY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 67. AMERICAS FUSION BIOPSY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 68. AMERICAS FUSION BIOPSY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
• TABLE 69. UNITED STATES FUSION BIOPSY MARKET SIZE, BY TYPES, 2018-2024 (USD MILLION)
• TABLE 70. UNITED STATES FUSION BIOPSY MARKET SIZE, BY TYPES, 2025-2030 (USD MILLION)
• TABLE 71. UNITED STATES FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 72. UNITED STATES FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 73. UNITED STATES FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
• TABLE 74. UNITED STATES FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
• TABLE 75. UNITED STATES FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
• TABLE 76. UNITED STATES FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
• TABLE 77. UNITED STATES FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 78. UNITED STATES FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 79. UNITED STATES FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 80. UNITED STATES FUSION BIOPSY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 81. UNITED STATES FUSION BIOPSY MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
• TABLE 82. UNITED STATES FUSION BIOPSY MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
• TABLE 83. CANADA FUSION BIOPSY MARKET SIZE, BY TYPES, 2018-2024 (USD MILLION)
• TABLE 84. CANADA FUSION BIOPSY MARKET SIZE, BY TYPES, 2025-2030 (USD MILLION)
• TABLE 85. CANADA FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 86. CANADA FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 87. CANADA FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
• TABLE 88. CANADA FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
• TABLE 89. CANADA FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
• TABLE 90. CANADA FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
• TABLE 91. CANADA FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 92. CANADA FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 93. CANADA FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 94. CANADA FUSION BIOPSY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 95. MEXICO FUSION BIOPSY MARKET SIZE, BY TYPES, 2018-2024 (USD MILLION)
• TABLE 96. MEXICO FUSION BIOPSY MARKET SIZE, BY TYPES, 2025-2030 (USD MILLION)
• TABLE 97. MEXICO FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 98. MEXICO FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 99. MEXICO FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
• TABLE 100. MEXICO FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
• TABLE 101. MEXICO FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
• TABLE 102. MEXICO FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
• TABLE 103. MEXICO FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 104. MEXICO FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 105. MEXICO FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 106. MEXICO FUSION BIOPSY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 107. BRAZIL FUSION BIOPSY MARKET SIZE, BY TYPES, 2018-2024 (USD MILLION)
• TABLE 108. BRAZIL FUSION BIOPSY MARKET SIZE, BY TYPES, 2025-2030 (USD MILLION)
• TABLE 109. BRAZIL FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 110. BRAZIL FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 111. BRAZIL FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
• TABLE 112. BRAZIL FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
• TABLE 113. BRAZIL FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
• TABLE 114. BRAZIL FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
• TABLE 115. BRAZIL FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 116. BRAZIL FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 117. BRAZIL FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 118. BRAZIL FUSION BIOPSY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 119. ARGENTINA FUSION BIOPSY MARKET SIZE, BY TYPES, 2018-2024 (USD MILLION)
• TABLE 120. ARGENTINA FUSION BIOPSY MARKET SIZE, BY TYPES, 2025-2030 (USD MILLION)
• TABLE 121. ARGENTINA FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 122. ARGENTINA FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 123. ARGENTINA FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
• TABLE 124. ARGENTINA FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
• TABLE 125. ARGENTINA FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
• TABLE 126. ARGENTINA FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
• TABLE 127. ARGENTINA FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 128. ARGENTINA FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 129. ARGENTINA FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 130. ARGENTINA FUSION BIOPSY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA FUSION BIOPSY MARKET SIZE, BY TYPES, 2018-2024 (USD MILLION)
• TABLE 132. EUROPE, MIDDLE EAST & AFRICA FUSION BIOPSY MARKET SIZE, BY TYPES, 2025-2030 (USD MILLION)
• TABLE 133. EUROPE, MIDDLE EAST & AFRICA FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 134. EUROPE, MIDDLE EAST & AFRICA FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 135. EUROPE, MIDDLE EAST & AFRICA FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
• TABLE 136. EUROPE, MIDDLE EAST & AFRICA FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
• TABLE 137. EUROPE, MIDDLE EAST & AFRICA FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
• TABLE 138. EUROPE, MIDDLE EAST & AFRICA FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
• TABLE 139. EUROPE, MIDDLE EAST & AFRICA FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 140. EUROPE, MIDDLE EAST & AFRICA FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 141. EUROPE, MIDDLE EAST & AFRICA FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 142. EUROPE, MIDDLE EAST & AFRICA FUSION BIOPSY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 143. EUROPE, MIDDLE EAST & AFRICA FUSION BIOPSY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 144. EUROPE, MIDDLE EAST & AFRICA FUSION BIOPSY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM FUSION BIOPSY MARKET SIZE, BY TYPES, 2018-2024 (USD MILLION)
• TABLE 146. UNITED KINGDOM FUSION BIOPSY MARKET SIZE, BY TYPES, 2025-2030 (USD MILLION)
• TABLE 147. UNITED KINGDOM FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 148. UNITED KINGDOM FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 149. UNITED KINGDOM FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
• TABLE 150. UNITED KINGDOM FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
• TABLE 151. UNITED KINGDOM FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
• TABLE 152. UNITED KINGDOM FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
• TABLE 153. UNITED KINGDOM FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 154. UNITED KINGDOM FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 155. UNITED KINGDOM FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 156. UNITED KINGDOM FUSION BIOPSY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 157. GERMANY FUSION BIOPSY MARKET SIZE, BY TYPES, 2018-2024 (USD MILLION)
• TABLE 158. GERMANY FUSION BIOPSY MARKET SIZE, BY TYPES, 2025-2030 (USD MILLION)
• TABLE 159. GERMANY FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 160. GERMANY FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 161. GERMANY FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
• TABLE 162. GERMANY FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
• TABLE 163. GERMANY FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
• TABLE 164. GERMANY FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
• TABLE 165. GERMANY FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 166. GERMANY FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 167. GERMANY FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 168. GERMANY FUSION BIOPSY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 169. FRANCE FUSION BIOPSY MARKET SIZE, BY TYPES, 2018-2024 (USD MILLION)
• TABLE 170. FRANCE FUSION BIOPSY MARKET SIZE, BY TYPES, 2025-2030 (USD MILLION)
• TABLE 171. FRANCE FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 172. FRANCE FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 173. FRANCE FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
• TABLE 174. FRANCE FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
• TABLE 175. FRANCE FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
• TABLE 176. FRANCE FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
• TABLE 177. FRANCE FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 178. FRANCE FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 179. FRANCE FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 180. FRANCE FUSION BIOPSY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 181. RUSSIA FUSION BIOPSY MARKET SIZE, BY TYPES, 2018-2024 (USD MILLION)
• TABLE 182. RUSSIA FUSION BIOPSY MARKET SIZE, BY TYPES, 2025-2030 (USD MILLION)
• TABLE 183. RUSSIA FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 184. RUSSIA FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 185. RUSSIA FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
• TABLE 186. RUSSIA FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
• TABLE 187. RUSSIA FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
• TABLE 188. RUSSIA FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
• TABLE 189. RUSSIA FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 190. RUSSIA FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 191. RUSSIA FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 192. RUSSIA FUSION BIOPSY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 193. ITALY FUSION BIOPSY MARKET SIZE, BY TYPES, 2018-2024 (USD MILLION)
• TABLE 194. ITALY FUSION BIOPSY MARKET SIZE, BY TYPES, 2025-2030 (USD MILLION)
• TABLE 195. ITALY FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 196. ITALY FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 197. ITALY FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
• TABLE 198. ITALY FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
• TABLE 199. ITALY FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
• TABLE 200. ITALY FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
• TABLE 201. ITALY FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 202. ITALY FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 203. ITALY FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 204. ITALY FUSION BIOPSY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 205. SPAIN FUSION BIOPSY MARKET SIZE, BY TYPES, 2018-2024 (USD MILLION)
• TABLE 206. SPAIN FUSION BIOPSY MARKET SIZE, BY TYPES, 2025-2030 (USD MILLION)
• TABLE 207. SPAIN FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 208. SPAIN FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 209. SPAIN FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
• TABLE 210. SPAIN FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
• TABLE 211. SPAIN FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
• TABLE 212. SPAIN FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
• TABLE 213. SPAIN FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 214. SPAIN FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 215. SPAIN FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 216. SPAIN FUSION BIOPSY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 217. UNITED ARAB EMIRATES FUSION BIOPSY MARKET SIZE, BY TYPES, 2018-2024 (USD MILLION)
• TABLE 218. UNITED ARAB EMIRATES FUSION BIOPSY MARKET SIZE, BY TYPES, 2025-2030 (USD MILLION)
• TABLE 219. UNITED ARAB EMIRATES FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 220. UNITED ARAB EMIRATES FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 221. UNITED ARAB EMIRATES FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
• TABLE 222. UNITED ARAB EMIRATES FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
• TABLE 223. UNITED ARAB EMIRATES FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
• TABLE 224. UNITED ARAB EMIRATES FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
• TABLE 225. UNITED ARAB EMIRATES FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 226. UNITED ARAB EMIRATES FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES FUSION BIOPSY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 229. SAUDI ARABIA FUSION BIOPSY MARKET SIZE, BY TYPES, 2018-2024 (USD MILLION)
• TABLE 230. SAUDI ARABIA FUSION BIOPSY MARKET SIZE, BY TYPES, 2025-2030 (USD MILLION)
• TABLE 231. SAUDI ARABIA FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 232. SAUDI ARABIA FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 233. SAUDI ARABIA FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
• TABLE 234. SAUDI ARABIA FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
• TABLE 235. SAUDI ARABIA FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
• TABLE 236. SAUDI ARABIA FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
• TABLE 237. SAUDI ARABIA FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 238. SAUDI ARABIA FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 239. SAUDI ARABIA FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 240. SAUDI ARABIA FUSION BIOPSY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 241. SOUTH AFRICA FUSION BIOPSY MARKET SIZE, BY TYPES, 2018-2024 (USD MILLION)
• TABLE 242. SOUTH AFRICA FUSION BIOPSY MARKET SIZE, BY TYPES, 2025-2030 (USD MILLION)
• TABLE 243. SOUTH AFRICA FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 244. SOUTH AFRICA FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 245. SOUTH AFRICA FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
• TABLE 246. SOUTH AFRICA FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
• TABLE 247. SOUTH AFRICA FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
• TABLE 248. SOUTH AFRICA FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
• TABLE 249. SOUTH AFRICA FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 250. SOUTH AFRICA FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 251. SOUTH AFRICA FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 252. SOUTH AFRICA FUSION BIOPSY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 253. DENMARK FUSION BIOPSY MARKET SIZE, BY TYPES, 2018-2024 (USD MILLION)
• TABLE 254. DENMARK FUSION BIOPSY MARKET SIZE, BY TYPES, 2025-2030 (USD MILLION)
• TABLE 255. DENMARK FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 256. DENMARK FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 257. DENMARK FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
• TABLE 258. DENMARK FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
• TABLE 259. DENMARK FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
• TABLE 260. DENMARK FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
• TABLE 261. DENMARK FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 262. DENMARK FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 263. DENMARK FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 264. DENMARK FUSION BIOPSY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 265. NETHERLANDS FUSION BIOPSY MARKET SIZE, BY TYPES, 2018-2024 (USD MILLION)
• TABLE 266. NETHERLANDS FUSION BIOPSY MARKET SIZE, BY TYPES, 2025-2030 (USD MILLION)
• TABLE 267. NETHERLANDS FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 268. NETHERLANDS FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 269. NETHERLANDS FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
• TABLE 270. NETHERLANDS FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
• TABLE 271. NETHERLANDS FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
• TABLE 272. NETHERLANDS FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
• TABLE 273. NETHERLANDS FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 274. NETHERLANDS FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 275. NETHERLANDS FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 276. NETHERLANDS FUSION BIOPSY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 277. QATAR FUSION BIOPSY MARKET SIZE, BY TYPES, 2018-2024 (USD MILLION)
• TABLE 278. QATAR FUSION BIOPSY MARKET SIZE, BY TYPES, 2025-2030 (USD MILLION)
• TABLE 279. QATAR FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 280. QATAR FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 281. QATAR FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
• TABLE 282. QATAR FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
• TABLE 283. QATAR FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
• TABLE 284. QATAR FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
• TABLE 285. QATAR FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 286. QATAR FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 287. QATAR FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 288. QATAR FUSION BIOPSY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 289. FINLAND FUSION BIOPSY MARKET SIZE, BY TYPES, 2018-2024 (USD MILLION)
• TABLE 290. FINLAND FUSION BIOPSY MARKET SIZE, BY TYPES, 2025-2030 (USD MILLION)
• TABLE 291. FINLAND FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 292. FINLAND FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 293. FINLAND FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
• TABLE 294. FINLAND FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
• TABLE 295. FINLAND FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
• TABLE 296. FINLAND FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
• TABLE 297. FINLAND FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 298. FINLAND FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 299. FINLAND FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 300. FINLAND FUSION BIOPSY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 301. SWEDEN FUSION BIOPSY MARKET SIZE, BY TYPES, 2018-2024 (USD MILLION)
• TABLE 302. SWEDEN FUSION BIOPSY MARKET SIZE, BY TYPES, 2025-2030 (USD MILLION)
• TABLE 303. SWEDEN FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 304. SWEDEN FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 305. SWEDEN FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
• TABLE 306. SWEDEN FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
• TABLE 307. SWEDEN FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
• TABLE 308. SWEDEN FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
• TABLE 309. SWEDEN FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 310. SWEDEN FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 311. SWEDEN FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 312. SWEDEN FUSION BIOPSY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 313. NIGERIA FUSION BIOPSY MARKET SIZE, BY TYPES, 2018-2024 (USD MILLION)
• TABLE 314. NIGERIA FUSION BIOPSY MARKET SIZE, BY TYPES, 2025-2030 (USD MILLION)
• TABLE 315. NIGERIA FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 316. NIGERIA FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 317. NIGERIA FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
• TABLE 318. NIGERIA FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
• TABLE 319. NIGERIA FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
• TABLE 320. NIGERIA FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
• TABLE 321. NIGERIA FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 322. NIGERIA FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 323. NIGERIA FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 324. NIGERIA FUSION BIOPSY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 325. EGYPT FUSION BIOPSY MARKET SIZE, BY TYPES, 2018-2024 (USD MILLION)
• TABLE 326. EGYPT FUSION BIOPSY MARKET SIZE, BY TYPES, 2025-2030 (USD MILLION)
• TABLE 327. EGYPT FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 328. EGYPT FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 329. EGYPT FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
• TABLE 330. EGYPT FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
• TABLE 331. EGYPT FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
• TABLE 332. EGYPT FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
• TABLE 333. EGYPT FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 334. EGYPT FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 335. EGYPT FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 336. EGYPT FUSION BIOPSY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 337. TURKEY FUSION BIOPSY MARKET SIZE, BY TYPES, 2018-2024 (USD MILLION)
• TABLE 338. TURKEY FUSION BIOPSY MARKET SIZE, BY TYPES, 2025-2030 (USD MILLION)
• TABLE 339. TURKEY FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 340. TURKEY FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 341. TURKEY FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
• TABLE 342. TURKEY FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
• TABLE 343. TURKEY FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
• TABLE 344. TURKEY FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
• TABLE 345. TURKEY FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 346. TURKEY FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 347. TURKEY FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 348. TURKEY FUSION BIOPSY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 349. ISRAEL FUSION BIOPSY MARKET SIZE, BY TYPES, 2018-2024 (USD MILLION)
• TABLE 350. ISRAEL FUSION BIOPSY MARKET SIZE, BY TYPES, 2025-2030 (USD MILLION)
• TABLE 351. ISRAEL FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 352. ISRAEL FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 353. ISRAEL FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
• TABLE 354. ISRAEL FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
• TABLE 355. ISRAEL FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
• TABLE 356. ISRAEL FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
• TABLE 357. ISRAEL FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 358. ISRAEL FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 359. ISRAEL FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 360. ISRAEL FUSION BIOPSY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 361. NORWAY FUSION BIOPSY MARKET SIZE, BY TYPES, 2018-2024 (USD MILLION)
• TABLE 362. NORWAY FUSION BIOPSY MARKET SIZE, BY TYPES, 2025-2030 (USD MILLION)
• TABLE 363. NORWAY FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 364. NORWAY FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 365. NORWAY FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
• TABLE 366. NORWAY FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
• TABLE 367. NORWAY FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
• TABLE 368. NORWAY FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
• TABLE 369. NORWAY FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 370. NORWAY FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 371. NORWAY FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 372. NORWAY FUSION BIOPSY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 373. POLAND FUSION BIOPSY MARKET SIZE, BY TYPES, 2018-2024 (USD MILLION)
• TABLE 374. POLAND FUSION BIOPSY MARKET SIZE, BY TYPES, 2025-2030 (USD MILLION)
• TABLE 375. POLAND FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 376. P